Showing results (121-130 of 156) with videos related to
Sort By:
Pageof 16
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2022
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendationsWallace J Brownlee, Christian Wolf, Hans-Peter Hartung, et al.Genes, Chromosomes & Cancer|August 10, 2006
Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variantsSabine Strehl, Margit König, Claus Meyer, et al.International Journal of Laboratory Hematology|January 10, 2019
Acute myeloid leukemia with t(10;11)(p11-12;q23.3): Results of Russian Pediatric AML registration studyElena Zerkalenkova, Svetlana Lebedeva, Anna Kazakova, et al.Nature Communications|October 25, 2017
Evolution of AF6-RAS association and its implications in mixed-lineage leukemiaMatthew J Smith, Elizabeth Ottoni, Noboru Ishiyama, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia IntergroupJürgen Krauter, Katharina Wagner, Irina Schäfer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2017
Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal TransitionAhmed Atef Ibrahim, Christian Schmithals, Erik Kowarz, et al.Haematologica|December 14, 2004
NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasmsThorben Kracht, Martin Schrappe, Sabine Strehl, et al.Leukemia|April 26, 2023
The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcomeMarius Külp, Patrizia Larghero, Julia Alten, et al.Iscience|July 8, 2022
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemiaMarius Külp, Anna Lena Siemund, Patrizia Larghero, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2015
Effective targeting of the P53-MDM2 axis in preclinical models of infant MLL-rearranged acute lymphoblastic leukemiaJennifer Richmond, Hernan Carol, Kathryn Evans, et al.Pageof 16